No More 'Hidden' Facilities, US FDA Tells Generic Sponsors
Executive Summary
Agency officials don't care if DMF holder doesn't give access to its entire facility list; FDA says industry is responsible for listing all facilities that could be used as part of ANDA.
You may also be interested in...
Missed ANDA Nods Mostly Due To 'Imminent Approval'
US FDA will miss goal dates to reach speedier generic drug application approvals, but says decisions will be case by case.
ANDA User Fee Misses Are Mostly Part Of 'Imminent Approval' Process
US FDA will miss goal dates to reach speedier generic drug application approvals, but says decisions will be case by case.
ANDA Sponsors Urged To Ask DMF Holders About 'Hidden Facilities'
FDA says 16% of ANDAs have an issue with "hidden facilities" that are listed in drug master files but not the ANDAs they are linked with; industry official offers some tips to bridge this communications gap with DMF holders.